Infectious Diseases
Overview
The journal 'Infectious Diseases' is a comprehensive source of research and knowledge in the field of infectious diseases. It covers a wide range of topics including epidemiology, pathogenesis, diagnosis, treatment, and prevention of various infectious diseases. With contributions from leading experts, the journal provides valuable insights and updates to healthcare professionals, researchers, and policymakers working towards combating infectious diseases globally.
Details
Details
Abbr.
Infect Dis (Lond)
Publisher
Informa Healthcare
Start
2015
End
Continuing
Frequency
Twelve issues per year
p-ISSN
2374-4235
e-ISSN
2374-4243
Country
United Kingdom
Language
English
Specialty
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 4133
83
SJR / Ranks: 4110
954
CiteScore / Ranks: 2975
6.90
JIF / Ranks: 1190
5.8
Recent Articles
1.
Thompson O, Pahlman L
Infect Dis (Lond)
. 2025 Mar;
:1-7.
PMID: 40080629
Background: Presence of a prosthetic joint entails a life-long risk of haematogenous periprosthetic joint infection (hPJI) during bacteraemia. For bacteraemia with the hPJI frequency has been described to be up...
2.
Ayalew S, Wegayehu T, Wondale B, Alemayehu D, Kebede D, Agize H, et al.
Infect Dis (Lond)
. 2025 Mar;
:1-13.
PMID: 40078121
Background: Bacterial confirmation in suspected tuberculosis lymphadenitis patients is challenging. This study evaluates plasma cell-free DNA as a diagnostic tool for tuberculosis lymphadenitis. Methods: A quantitative PCR assay targeting IS,...
3.
Ceccarelli G, Branda F, Albanese M, Scarpa F, Acharya K, Yon D, et al.
Infect Dis (Lond)
. 2025 Mar;
:1-3.
PMID: 40047715
No abstract available.
4.
Fouad A, Nicolau S, Tamma P, Simner P, Nicolau D, Gill C
Infect Dis (Lond)
. 2025 Mar;
:1-11.
PMID: 40042366
Background: with difficult-to-treat resistance is a clinical burden. Ceftolozane/tazobactam is recommended for difficult-to-treat although cefiderocol represents an option due to its potency against isolates with ceftolozane/tazobactam-resistance. Head-to-head data assessing these...
5.
Laupland K, Stewart A, Edwards F, Harris P, Coulter S
Infect Dis (Lond)
. 2025 Mar;
:1-7.
PMID: 40040413
Background: Few studies have examined infection risk related to opioid misuse in non-selected populations. Objectives: We sought to identify clinical factors and outcomes among adults with opioid use disorder-associated bloodstream...
6.
Christiansen N, Lindvig S, Johansen I, Kehrer M
Infect Dis (Lond)
. 2025 Mar;
:1-8.
PMID: 40028767
Introduction: is the most frequent fungal organism causing vertebral spondylodiskitis. Given limited research, this study aimed to describe patient characteristics, treatment, and outcomes of the spondylodiscitis patients in Southern Denmark...
7.
Lu J, Li Q, Zhang C, Li Z, Guo Q, Cao Z, et al.
Infect Dis (Lond)
. 2025 Feb;
:1-11.
PMID: 40017260
Background: Hepatitis E virus (HEV) infection is endemic in China. However, there are scarce data of HEV infection among hospital attendees seeking medical treatment or examination for various reasons. Objective:...
8.
Tubiana S, Rontani M, Herlemont P, Dray-Spira R, Zureik M, Weill A, et al.
Infect Dis (Lond)
. 2025 Feb;
:1-11.
PMID: 40016873
Context: Increased risks of death and hospitalisation for organ disorders after discharge for COVID-19 hospitalisation have been reported but their persistence is unknown. Methods: We conducted a nationwide cohort study...
9.
Peverengo L, Peretti L, Warszatska M, Moscatelli G, Moroni S, Gonzalez N, et al.
Infect Dis (Lond)
. 2025 Feb;
:1-11.
PMID: 39998826
Background: The diagnosis of congenital Chagas disease in newborns relies on the microhematocrit method which exhibits reduced sensitivity during the early stages of infection and quantitative PCR for , which...
10.
Uez O, Culasso A, Lerman A, Cimmino C, Campos R, Marcone D
Infect Dis (Lond)
. 2025 Feb;
:1-14.
PMID: 39982428
Background: Influenza A viruses are a major cause of viral respiratory infections in humans, leading to a spectrum of diseases ranging from mild to severe, particularly in high-risk groups. Monitoring...